Selvarajah D, Wilkinson I D, Emery C J, Shaw P J, Griffiths P D, Gandhi R, Tesfaye S
Diabetes Research Unit, Royal Hallamshire Hospital, Sheffield, S10 2JF, UK.
Diabetologia. 2008 Nov;51(11):2088-92. doi: 10.1007/s00125-008-1139-0. Epub 2008 Sep 5.
AIMS/HYPOTHESIS: Although clear peripheral nerve pathological abnormalities have been demonstrated in diabetic peripheral neuropathy (DPN), there is little information with regard to brain involvement. Our aim was to use in vivo proton magnetic resonance specroscopy (H-MRS) in patients with DPN in order to assess the neuro-chemical status of the thalamus, which acts as the gateway to the brain for somatosensory information.
Participants included 18 type 1 diabetic men (eight without DPN, ten with DPN) and six non-diabetic healthy volunteers, who all underwent detailed clinical and neurophysiological assessments yielding a Neuropathy Composite Score (NCS) derived from Neuropathy Impairment Score of the Lower Limbs plus seven tests of nerve function prior to investigation via a single-voxel H-MRS technique, which was used to sample ventral posterior thalamic parenchyma. Spectroscopic resonances including those due to N-acetyl aspartate (NAA) were assessed at both short and long echo-time, providing putative indicators of neuronal function and integrity, respectively.
At long echo-time we observed significantly lower NAA:creatine (p = 0.04) and NAA:choline (p = 0.02) ratios in DPN patients than in the other groups. No group differences were detected at short echo-time. We found a significant positive association between both sural amplitude (rho = 0.61, p = 0.004) and nerve conduction velocity (r = 0.58, p = 0.006) and NAA:creatine signal among participants with diabetes. Vibration detection threshold (rho = -0.70, p = 0.004) was significantly related to NAA:choline ratio. Heart rate variability with deep breathing (rho = -0.46, p = 0.05) and NCS (rho = -0.53, p = 0.03) were significantly related to NAA:creatine ratio.
CONCLUSIONS/INTERPRETATION: The significantly lower NAA:creatine ratio in DPN is suggestive of thalamic neuronal dysfunction, while the lack of difference in short echo-time between the groups does not suggest neuronal loss. Taken together with the observed correlations between NAA and neurophysiological assessments, these findings provide evidence for thalamic neuronal involvement in DPN.
目的/假设:尽管在糖尿病周围神经病变(DPN)中已证实存在明显的周围神经病理异常,但关于脑部受累的信息却很少。我们的目的是对DPN患者进行活体质子磁共振波谱(H-MRS)检查,以评估丘脑的神经化学状态,丘脑是躯体感觉信息进入大脑的门户。
参与者包括18名1型糖尿病男性(8名无DPN,10名有DPN)和6名非糖尿病健康志愿者,他们均接受了详细的临床和神经生理学评估,得出神经病变综合评分(NCS),该评分源自下肢神经病变损害评分加上7项神经功能测试。在通过单体素H-MRS技术进行检查之前,该技术用于对丘脑腹后实质进行采样。在短回波时间和长回波时间评估了包括N-乙酰天门冬氨酸(NAA)引起的磁共振波谱共振,分别提供了神经元功能和完整性的推定指标。
在长回波时间,我们观察到DPN患者的NAA:肌酸比值(p = 0.04)和NAA:胆碱比值(p = 0.02)明显低于其他组。在短回波时间未检测到组间差异。我们发现,在糖尿病患者中,腓肠神经波幅(rho = 0.61,p = 0.004)和神经传导速度(r = 0.58,p = 0.006)与NAA:肌酸信号之间均存在显著正相关。振动检测阈值(rho = -0.70,p = 0.004)与NAA:胆碱比值显著相关。深呼吸时的心率变异性(rho = -0.46,p = 0.05)和NCS(rho = -0.53,p = 0.03)与NAA:肌酸比值显著相关。
结论/解读:DPN患者中NAA:肌酸比值显著降低提示丘脑神经元功能障碍,而组间短回波时间无差异并不提示神经元丢失。结合观察到的NAA与神经生理学评估之间的相关性,这些发现为丘脑神经元参与DPN提供了证据。